Yong‐June Kim

3.1k total citations
126 papers, 2.3k citations indexed

About

Yong‐June Kim is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Yong‐June Kim has authored 126 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Pulmonary and Respiratory Medicine, 56 papers in Molecular Biology and 50 papers in Surgery. Recurrent topics in Yong‐June Kim's work include Bladder and Urothelial Cancer Treatments (45 papers), Epigenetics and DNA Methylation (27 papers) and Renal cell carcinoma treatment (26 papers). Yong‐June Kim is often cited by papers focused on Bladder and Urothelial Cancer Treatments (45 papers), Epigenetics and DNA Methylation (27 papers) and Renal cell carcinoma treatment (26 papers). Yong‐June Kim collaborates with scholars based in South Korea, United States and Ethiopia. Yong‐June Kim's co-authors include Wun‐Jae Kim, Sang‐Cheol Lee, Seok Joong Yun, Yun‐Sok Ha, Seon‐Kyu Kim, Won Tae Kim, Ho Won Kang, Pildu Jeong, Sung‐Kwon Moon and Suk‐Chul Bae and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yong‐June Kim

121 papers receiving 2.3k citations

Peers

Countries citing papers authored by Yong‐June Kim

Since Specialization

Citations

This map shows the geographic impact of Yong‐June Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong‐June Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong‐June Kim more than expected).

Fields of papers citing papers by Yong‐June Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong‐June Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong‐June Kim. The network helps show where Yong‐June Kim may publish in the future.

Co-authorship network of co-authors of Yong‐June Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Yong‐June Kim. A scholar is included among the top collaborators of Yong‐June Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong‐June Kim. Yong‐June Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incidence and mortality of upper tract urothelial carcinoma in Korea: A nationwide population-based study conducted from 2002 to 2020 2025 ·Investigative and Clinical Urology ·(unknown), Yun‐Sok Ha, Mina Kim, (unknown), Won Tae Kim, Yong‐June Kim, Seok Joong Yun, Sang‐Cheol Lee, Ho Won Kang	0
2	Machine learning models for predicting the onset of chronic kidney disease after surgery in patients with renal cell carcinoma 2024 ·BMC Medical Informatics and Decision Making ·(unknown), Seok‐Soo Byun, Jung Kwon Kim, Chang Wook Jeong, Cheol Kwak, Eu Chang Hwang, Seok Ho Kang, Jinsoo Chung, Yong‐June Kim, Yun‐Sok Ha, Sung‐Hoo Hong	2
3	Apolipoprotein L1 is a tumor suppressor in clear cell renal cell carcinoma metastasis 2024 ·Frontiers in Oncology ·(unknown), (unknown), Jae‐A Han, (unknown), (unknown), Yong‐June Kim, Seongho Ryu	1
4	Machine learning based prediction for oncologic outcomes of renal cell carcinoma after surgery using Korean Renal Cell Carcinoma (KORCC) database 2023 ·Scientific Reports ·Jung Kwon Kim, Sangchul Lee, Sung Kyu Hong, Cheol Kwak, Chang Wook Jeong, Seok Ho Kang, Sung‐Hoo Hong, Yong‐June Kim, Jinsoo Chung, Eu Chang Hwang, Tae Gyun Kwon, Seok‐Soo Byun, (unknown), Junghyun Lim, Jiyeon Kim, (unknown)	6
5	Production of Highly Uniform Midbrain Organoids from Human Pluripotent Stem Cells 2023 ·Stem Cells International ·Xuerui Yao, (unknown), Kee-Pyo Kim, Hyogeun Shin, (unknown), Hao Guo, Yong‐Nan Xu, Yinghua Li, (unknown), Jeongwoo Kwon, (unknown), Chanhyeok Park, Yong‐June Kim, Lin Wang, Kwonho Hong, Qilong Cao, Il‐Joo Cho, (unknown), (unknown)	4
6	Optimal management of renal cell carcinoma in octogenarians: Retrospective analysis using updated Korean Renal Cell Carcinoma (KORCC) database 2023 ·PLoS ONE ·Jung Kwon Kim, (unknown), Cheol Kwak, Chang Wook Jeong, Seok Ho Kang, Sung‐Hoo Hong, Yong‐June Kim, Jinsoo Chung, Eu Chang Hwang, Tae Gyun Kwon, Seok‐Soo Byun	0
7	Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone 2022 ·Investigative and Clinical Urology ·Ho Won Kang, Young Joon Byun, (unknown), Kyeong Kim, Xuan‐Mei Piao, (unknown), Sung‐Kwon Moon, Yung Hyun Choi, Won Tae Kim, Yong‐June Kim, Sang‐Cheol Lee, Seok Joong Yun, Wun‐Jae Kim	6
8	Machine learning-based prediction model for late recurrence after surgery in patients with renal cell carcinoma 2022 ·BMC Medical Informatics and Decision Making ·Hyung Min Kim, Seok‐Soo Byun, Jung Kwon Kim, Chang Wook Jeong, Cheol Kwak, Eu Chang Hwang, Seok Ho Kang, Jinsoo Chung, Yong‐June Kim, Yun‐Sok Ha, Sung‐Hoo Hong	9
9	The prognostic value of the pretreatment serum albumin to globulin ratio for predicting adverse pathology in patients undergoing radical prostatectomy for prostate cancer 2021 ·Investigative and Clinical Urology ·Jae-Wook Chung, Yun‐Sok Ha, (unknown), Seung Chol Park, Taek Won Kang, Young Beom Jeong, Sung‐Woo Park, Jinsung Park, Eun Sang Yoo, Tae Gyun Kwon, (unknown), Ho Won Kang, Won Tae Kim, Yong‐June Kim, Sang‐Cheol Lee, Wun‐Jae Kim, Seok Joong Yun, Tae‐Hwan Kim	9
10	Effect of pre-operative internal obturator muscle mass index in MRI on biochemical recurrence of prostate cancer patients after radical prostatectomy: a multi-center study 2021 ·BMC Urology ·Won Tae Kim, Ho Won Kang, (unknown), Yong‐June Kim, Sang Cheol Lee, Wun‐Jae Kim, (unknown), (unknown), Tae Gyun Kwon, Jinsung Park, Seung Chol Park, Young Beom Jeong, Taek Won Kang, Heung‐Woo Park, Seok Joong Yun	1
11	A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone 2020 ·Investigative and Clinical Urology ·Ho Won Kang, (unknown), Young Joon Byun, Pildu Jeong, (unknown), (unknown), Won Tae Kim, Yong‐June Kim, Sang‐Cheol Lee, Seok Joong Yun, Wun‐Jae Kim	7
12	Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell Carcinoma 2019 ·Journal of Korean Medical Science ·Ho Won Kang, (unknown), (unknown), Young Joon Byun, Xuan‐Mei Piao, (unknown), Won Tae Kim, Seok Joong Yun, (unknown), Ho Sun Shon, Keun Ho Ryu, Sang‐Cheol Lee, Wun‐Jae Kim, Yong‐June Kim	17
13	The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma 2019 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Ho Won Kang, (unknown), Won Tae Kim, Seok Joong Yun, Sang‐Cheol Lee, Wun‐Jae Kim, Eu Chang Hwang, Seok Ho Kang, Sung‐Hoo Hong, Jinsoo Chung, Tae Gyun Kwon, Hyeon Hoe Kim, Cheol Kwak, Seok‐Soo Byun, Yong‐June Kim	27
14	Impact of Young Age at Diagnosis on Survival in Patients with Surgically Treated Renal Cell Carcinoma: a Multicenter Study 2016 ·Journal of Korean Medical Science ·Ho Won Kang, (unknown), Won Tae Kim, Seok Joong Yun, Sang‐Cheol Lee, Wun‐Jae Kim, Eu Chang Hwang, Seok Ho Kang, Sung‐Hoo Hong, Jinsoo Chung, Tae Gyun Kwon, Hyeon Hoe Kim, Cheol Kwak, Seok‐Soo Byun, Yong‐June Kim, (unknown)	22
15	Clinical Significance of Subclassification of Papillary Renal Cell Carcinoma: Comparison of Clinicopathologic Parameters and Oncologic Outcomes Between Papillary Histologic Subtypes 1 and 2 Using the Korean Renal Cell Carcinoma Database 2016 ·Clinical Genitourinary Cancer ·Yun‐Sok Ha, Jae-Wook Chung, Seock Hwan Choi, Jun Nyung Lee, Hyun Tae Kim, Tae‐Hwan Kim, Sung Kwang Chung, Seok‐Soo Byun, Eu Chang Hwang, Seok Ho Kang, Sung‐Hoo Hong, Jinsoo Chung, Cheol Kwak, Yong‐June Kim, Tae Gyun Kwon	15
16	Effect of Renal Insufficiency on Stone Recurrence in Patients with Urolithiasis 2014 ·Journal of Korean Medical Science ·Ho Won Kang, (unknown), Won Tae Kim, Yong‐June Kim, Seok Joong Yun, Sang‐Cheol Lee, Wun‐Jae Kim	13
17	Glutathione S-transferase M1 and T1 polymorphisms: Susceptibility and outcomes in muscle invasive bladder cancer patients 2013 ·European Journal of Cancer ·Ho Won Kang, Phil Hyun Song, Yun‐Sok Ha, Won Tae Kim, Yong‐June Kim, Seok Joong Yun, Sang‐Cheol Lee, Yung Hyun Choi, Sung‐Kwon Moon, Wun‐Jae Kim	21
18	Predictive Factors for Late Recurrence in Patients With Stage T1 Clear Cell Renal Cell Carcinoma: A Multiinstitutional Study 2012 ·Clinical Genitourinary Cancer ·Yun‐Sok Ha, Yong Hyun Park, Seok Ho Kang, Sung‐Hoo Hong, Tae‐Kon Hwang, Seok‐Soo Byun, Yong‐June Kim	17
19	Gene Signatures for the Prediction of Response to Bacillus Calmette-Guérin Immunotherapy in Primary pT1 Bladder Cancers 2010 ·Clinical Cancer Research ·Yong‐June Kim, Yun‐Sok Ha, Seon‐Kyu Kim, (unknown), (unknown), Minju Kim, Sung‐Kwon Moon, Yung Hyun Choi, Wun‐Jae Kim	46
20	Alpha-Methylacyl-Coenzyme A Racemase-Expressing Urachal Adenocarcinoma of the Abdominal Wall 2010 ·Korean journal of urology ·Yun‐Sok Ha, Youngwon Kim, (unknown), Ok-Jun Lee, Yong‐June Kim, Seok Joong Yun, Sang‐Cheol Lee, Wun‐Jae Kim	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact